Bill to Speed Approvals for Drugs Is Cut Back

The New York Times, April 30, 2015. Legislation that would have accelerated the pace of federal drug approvals in a way that critics said threatened to erode patient safety was formally released this week, in a scaled-back version with many of the most controversial provisions left out.

Read More »